Michael Barish, PhD
Advertisement
Articles by Michael Barish, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
What Do Physicians and Patients Think About ADCs as Cancer Treatment?
3
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
4
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
5
